Long‐term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)

Aims Latent autoimmune diabetes in adults (LADA) is diagnosed in up to 12% of adults with clinically diagnosed type 2 diabetes (T2D). LADA tends to have healthier cardiovascular (CV) risk profiles than T2D, but it remains uncertain whether the risk of CV events differs between the two. We examined the risk of CV events in patients enrolled in the United Kingdom Prospective Diabetes Study (UKPDS) according to LADA status. Materials and methods Diabetes autoantibodies (AAb) were measured in 5062 UKPDS participants. The incidence of major adverse CV events (MACE), defined as CV death, non‐fatal myocardial infarction or non‐fatal stroke, was compared in those with LADA (≥1 AAb test positive) and those without LADA (AAb negative). Results There were 567 participants (11.2%) with LADA. Compared with participants with T2D, they were younger, with higher mean HbA1c and HDL‐cholesterol values, and with lower body mass index and total cholesterol and systolic blood pressure values (all P